Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com 16 November 2026 Dear Shareholder, Neurizon Therapeutics Limited – General Meeting of Shareholders – 17 December 2026 Notice is hereby given that the General Meeting of Shareholders of Neurizon Therapeutics Limited...
Neurizon Therapeutics: Notice of General Meeting/Proxy Form
Filed with ASX · · 22 pages · English
Summary by 6ix AI
Neurizon Therapeutics Limited has issued a notice for a general meeting of shareholders scheduled to be held virtually. The meeting will take place on a specified date and time, and shareholders are encouraged to participate either online or by proxy. Shareholders are advised to review the accompanying explanatory statement and proxy form for detailed information on the resolutions to be voted on.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Neurizon Therapeutics Limited on 6ix
Story so far
Earlier from Neurizon Therapeutics
- Prospectus
- Share Purchase Plan and Options Offer Open
- First Regimen I patient enters Active Treatment Extension
- R&D Facility Extension and Second Drawdown Completed
- Change in substantial holding
Later from Neurizon Therapeutics
All Neurizon Therapeutics news releasesFollow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics